PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.16%
Net income growth above 1.5x AVGO's 4.77%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
1.78%
Some D&A expansion while AVGO is negative at -1.79%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-870.83%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
8.39%
SBC growth while AVGO is negative at -0.26%. John Neff would see competitor possibly controlling share issuance more tightly.
56.45%
Well above AVGO's 69.11% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
5.38%
AR growth while AVGO is negative at -14.53%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
22.64%
Inventory growth well above AVGO's 34.08%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
198.57%
AP growth of 198.57% while AVGO is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
316.67%
Lower 'other working capital' growth vs. AVGO's 651.16%. David Dodd would see fewer unexpected short-term demands on cash.
113.97%
Lower 'other non-cash' growth vs. AVGO's 417.02%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
43.12%
Operating cash flow growth above 1.5x AVGO's 21.72%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
38.59%
CapEx growth well above AVGO's 15.84%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-350.00%
Negative yoy acquisition while AVGO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-7.29%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-30.02%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
350.00%
Growth well above AVGO's 212.50%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-99.14%
Both yoy lines negative, with AVGO at -0.32%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-98.41%
Negative yoy issuance while AVGO is 5800.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
23.27%
We have some buyback growth while AVGO is negative at -6.16%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.